Author:
Belt E. J. Th.,te Velde E. A.,Krijgsman O.,Brosens R. P. M.,Tijssen M.,van Essen H. F.,Stockmann H. B. A. C.,Bril H.,Carvalho B.,Ylstra B.,Bonjer H. J.,Meijer G. A.
Publisher
Springer Science and Business Media LLC
Reference58 articles.
1. World Health Organisation, Data and statistics. www.who.int/mediacentre/factsheets/fs297/en . Accessed 30 Dec 2010.
2. Sobin L, Gospodarowicz M, Wittekind C. TNM Classification of malignant tumours. 7th ed. Chichester, U.K.: Wiley; 2009.
3. Gill S, Loprinzi CL, Sargent DJ, Thomé SD, Alberts SR, Haller DG, et al. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol. 2004;22:1797–806.
4. Andre T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350:2343–51.
5. Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators. J Clin Oncol. 1999;17:1356–63.
Cited by
72 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献